DuPont de Nemours, Inc.

NYSE:DD Lagerbericht

Marktkapitalisierung: US$19.1b

DuPont de Nemours Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

DuPont de Nemours wird ein jährliches Gewinn- und Umsatzwachstum von 22.9% bzw. 4.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 24.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.7% betragen.

Wichtige Informationen

22.9%

Wachstumsrate der Gewinne

24.43%

EPS-Wachstumsrate

Chemicals Gewinnwachstum17.3%
Wachstumsrate der Einnahmen4.1%
Zukünftige Eigenkapitalrendite7.67%
Analystenabdeckung

Good

Zuletzt aktualisiert19 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update • May 07

DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside

Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.
Seeking Alpha • May 07

DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)

Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking Alpha
Narrativ-Update • Apr 23

DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside

Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Narrativ-Update • Apr 08

DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook

Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.
Narrativ-Update • Mar 24

DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside

Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Narrativ-Update • Mar 09

DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside

Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.
Narrativ-Update • Feb 23

DD: New Guidance And Product Pipeline Will Support Future Upside

Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.
Analyseartikel • Feb 17

There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings

The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...
Narrativ-Update • Feb 09

DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside

Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).
Narrativ-Update • Jan 26

DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity

Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).
Narrativ-Update • Jan 12

DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook

Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).
Narrativ-Update • Dec 27

DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity

Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.
Narrativ-Update • Dec 13

DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook

Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.
Narrativ-Update • Nov 29

DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground

Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.
Narrativ-Update • Nov 15

DD: Future Share Buybacks Will Unlock Value Amid Uncertainty

Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.
Analyseartikel • Nov 09

DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year

DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...
Narrativ-Update • Nov 01

DD: Qnity Separation And Water Solutions Will Drive Outperformance

Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.
Narrativ-Update • Oct 17

Electronics, Healthcare And Water Will Drive Future Success

Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.
Narrativ-Update • Sep 24

Electronics, Healthcare And Water Will Drive Future Success

Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.
Narrativ-Update • Sep 04

Electronics, Healthcare And Water Will Drive Future Success

As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.
Analyseartikel • Jul 23

Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...
Seeking Alpha • Apr 07

DuPont: Upgrading To Hold Amid China Risks

Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:DD - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20287,7458821,0051,50010
12/31/20277,4517959861,37414
12/31/20267,1677259911,37714
3/31/20266,9181329011,214N/A
12/31/20256,849571,0791,412N/A
9/30/20255,7224791,8941,900N/A
6/30/20255,5126301,7431,957N/A
3/31/20255,400-2341,5361,736N/A
12/31/20246,719-1311,5621,847N/A
9/30/202411,1614219731,837N/A
6/30/202411,3572601,2051,801N/A
3/31/202411,9814041,4202,037N/A
12/31/20236,614-1011,5931,918N/A
9/30/202312,2748956091,243N/A
6/30/202312,533963321991N/A
3/31/202312,7611,06579722N/A
12/31/202213,0171,012-74588N/A
9/30/202213,1591,0642,9721,335N/A
6/30/202213,0419601,0301,758N/A
3/31/202212,8239891,2642,112N/A
12/31/202112,5661,1591,4932,281N/A
9/30/202113,0701,453-3382,961N/A
6/30/202113,5001,2862,4113,393N/A
3/31/202113,685-1,4962,7513,755N/A
12/31/202011,128-1,3772,8314,095N/A
9/30/202015,792-2,6941,8253,372N/A
6/30/202017,589-2,4061,3362,980N/A
3/31/202019,768-1,147342,101N/A
12/31/201915,436-227N/A1,409N/A
9/30/201921,765-620N/A5,932N/A
6/30/201922,022-896N/A4,727N/A
3/31/201922,411230N/A6,894N/A
12/31/201822,594233N/A4,731N/A
9/30/201837,203-1,249N/A1,387N/A
6/30/201846,874-809N/A-711N/A
3/31/201854,851517N/A-2,826N/A
12/31/201711,67288N/A-765N/A
9/30/201755,4382,698N/A-641N/A
6/30/201752,5672,882N/A3,132N/A
3/31/201750,6854,672N/A5,385N/A
12/31/201648,1583,956N/A-2,957N/A
9/30/201646,6007,490N/A6,060N/A
6/30/201646,1538,056N/A7,219N/A
3/31/201647,1116,079N/A6,397N/A
12/31/201548,7787,294N/A7,607N/A
9/30/201551,7004,520N/A7,932N/A
6/30/201554,0694,084N/A7,196N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DDDas prognostizierte Gewinnwachstum (22.9% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: DDDie Erträge des Unternehmens (22.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).

Hohe Wachstumserträge: DDEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: DDDie Einnahmen des Unternehmens (4.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.6% pro Jahr).

Hohe Wachstumseinnahmen: DDDie Einnahmen des Unternehmens (4.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: DDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.7%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/20 05:22
Aktienkurs zum Tagesende2026/05/20 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

DuPont de Nemours, Inc. wird von 38 Analysten beobachtet. 14 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
William SeleskyArgus Research Company
Patrick Duffy FischerBarclays
Michael LeitheadBarclays